Earnings Preview For NovaBay Pharmaceuticals
Portfolio Pulse from Benzinga Insights
NovaBay Pharmaceuticals (AMEX:NBY) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.40. The company's stock price has historically been affected by its earnings performance, with a miss in EPS last quarter leading to a 7.14% drop in share price. Over the last 52-week period, shares are down 87.76%.
November 08, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NovaBay Pharmaceuticals is expected to report an EPS of $-0.40. Last quarter's EPS miss led to a 7.14% drop in share price. Over the last year, shares are down 87.76%.
NovaBay Pharmaceuticals' stock price has historically been affected by its earnings performance. Given that the company missed its EPS estimate last quarter, which led to a significant drop in its share price, and the overall negative return of its shares over the past year, it is likely that the upcoming earnings report could have a negative impact on the stock price, especially if the company fails to meet the EPS estimate again.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100